-
1
-
-
0035066332
-
Alzheimer's disease: Genes, proteins, and therapy
-
11274343
-
Alzheimer's disease: genes, proteins, and therapy. DJ Selkoe, Physiol Rev 2001 81 741 766 11274343
-
(2001)
Physiol Rev
, vol.81
, pp. 741-766
-
-
Selkoe, D.J.1
-
2
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
10.1126/science.1072994. 12130773
-
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. J Hardy DJ Selkoe, Science 2002 297 353 356 10.1126/science.1072994 12130773
-
(2002)
Science
, vol.297
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
3
-
-
13544272023
-
The Abeta hypothesis: Leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease
-
15779241
-
The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. TE Golde, Brain Pathol 2005 15 84 87 15779241
-
(2005)
Brain Pathol
, vol.15
, pp. 84-87
-
-
Golde, T.E.1
-
4
-
-
0029379605
-
Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease
-
7561836
-
Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. F Checler, J Neurochem 1995 65 1431 1444 7561836
-
(1995)
J Neurochem
, vol.65
, pp. 1431-1444
-
-
Checler, F.1
-
5
-
-
17644419726
-
Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation
-
10.1111/j.1601-183X.2005.00086.x. 15810902
-
Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. P Marambaud NK Robakis, Genes Brain Behav 2005 4 134 146 10.1111/j.1601-183X.2005.00086.x 15810902
-
(2005)
Genes Brain Behav
, vol.4
, pp. 134-146
-
-
Marambaud, P.1
Robakis, N.K.2
-
6
-
-
0035829592
-
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity
-
10.1038/35102591. 11700559
-
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. S Weggen JL Eriksen P Das SA Sagi R Wang CU Pietrzik KA Findlay TE Smith MP Murphy T Bulter DE Kang N Marquez-Sterling TE Golde EH Koo, Nature 2001 414 212 216 10.1038/35102591 11700559
-
(2001)
Nature
, vol.414
, pp. 212-216
-
-
Weggen, S.1
Eriksen, J.L.2
Das, P.3
Sagi, S.A.4
Wang, R.5
Pietrzik, C.U.6
Findlay, K.A.7
Smith, T.E.8
Murphy, M.P.9
Bulter, T.10
Kang, D.E.11
Marquez-Sterling, N.12
Golde, T.E.13
Koo, E.H.14
-
7
-
-
0033535553
-
Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
-
10.1038/19077. 10206644
-
Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. MS Wolfe W Xia BL Ostaszewski TS Diehl WT Kimberly DJ Selkoe, Nature 1999 398 513 517 10.1038/19077 10206644
-
(1999)
Nature
, vol.398
, pp. 513-517
-
-
Wolfe, M.S.1
Xia, W.2
Ostaszewski, B.L.3
Diehl, T.S.4
Kimberly, W.T.5
Selkoe, D.J.6
-
8
-
-
0037173071
-
The aspartate-257 of presenilin 1 is indispensable for mouse development and production of β-amyloid peptides through β-catenin-independent mechanisms
-
DOI 10.1073/pnas.132045399
-
The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. X Xia P Wang X Sun S Soriano WK Shum H Yamaguchi ME Trumbauer A Takashima EH Koo H Zheng, Proc Natl Acad Sci U S A 2002 99 8760 8765 12070348 10.1073/pnas.132045399 (Pubitemid 34693633)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.13
, pp. 8760-8765
-
-
Xia, X.1
Wang, P.2
Sun, X.3
Soriano, S.4
Shum, W.-K.5
Yamaguchi, H.6
Trumbauer, M.E.7
Takashima, A.8
Koo, E.H.9
Zheng, H.10
-
9
-
-
0036108482
-
Comparative antibiotic eradication of mycoplasma infections from continuous cell lines
-
10.1290/1071-2690(2002)038<0086:CAEOMI>2.0.CO;2. 11929000
-
Comparative antibiotic eradication of mycoplasma infections from continuous cell lines. CC Uphoff HG Drexler, In Vitro Cell Dev Biol Anim 2002 38 86 89 10.1290/1071-2690(2002)038<0086:CAEOMI>2.0.CO;2 11929000
-
(2002)
Vitro Cell Dev Biol Anim
, vol.38
, pp. 86-89
-
-
Uphoff, C.C.1
Drexler, H.G.2
-
10
-
-
0028786848
-
Mycoplasmas and oncogenesis: Persistent infection and multistage malignant transformation
-
7479753. 10.1073/pnas.92.22.10197
-
Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. S Tsai DJ Wear JW Shih SC Lo, Proc Natl Acad Sci U S A 1995 92 10197 10201 7479753 10.1073/pnas.92.22.10197
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 10197-10201
-
-
Tsai, S.1
Wear, D.J.2
Shih, J.W.3
Lo, S.C.4
-
11
-
-
0032408808
-
Mycoplasma infection can sensitize host cells to apoptosis through contribution of apoptotic-like endonuclease(s)
-
10.1046/j.1440-1711.1998.00781.x. 9893030
-
Mycoplasma infection can sensitize host cells to apoptosis through contribution of apoptotic-like endonuclease(s). IA Sokolova AT Vaughan NN Khodarev, Immunol Cell Biol 1998 76 526 534 10.1046/j.1440-1711.1998.00781.x 9893030
-
(1998)
Immunol Cell Biol
, vol.76
, pp. 526-534
-
-
Sokolova, I.A.1
Vaughan, A.T.2
Khodarev, N.N.3
-
12
-
-
0024964735
-
Mycoplasma infection of cultured cells
-
10.1038/339487a0. 2725683
-
Mycoplasma infection of cultured cells. RJ Hay ML Macy TR Chen, Nature 1989 339 487 488 10.1038/339487a0 2725683
-
(1989)
Nature
, vol.339
, pp. 487-488
-
-
Hay, R.J.1
MacY, M.L.2
Chen, T.R.3
-
13
-
-
0002349924
-
Contamination of cell culture, mycoplasma
-
Contamination of cell culture, mycoplasma. HG Drexler CC Uphoff, Encyclopedia of cell technology Volume I Edited by : Spier RE New York, John Wiley & Sons, Inc 2000 609 627
-
(2000)
Encyclopedia of Cell Technology Volume i Edited by : Spier RE New York, John Wiley & Sons, Inc
, pp. 609-627
-
-
Drexler, H.G.1
Uphoff, C.C.2
-
14
-
-
0036102188
-
Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines
-
10.1290/1071-2690(2002)038<0079:CPAFDO>2.0.CO;2. 11928999
-
Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines. CC Uphoff HG Drexler, In Vitro Cell Dev Biol Anim 2002 38 79 85 10.1290/1071-2690(2002)038<0079:CPAFDO>2.0.CO;2 11928999
-
(2002)
Vitro Cell Dev Biol Anim
, vol.38
, pp. 79-85
-
-
Uphoff, C.C.1
Drexler, H.G.2
-
15
-
-
14944344493
-
Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration
-
10.1196/annals.1332.001. 15681797
-
Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. AJ Turner L Fisk NN Nalivaeva, Ann N Y Acad Sci 2004 1035 1 20 10.1196/annals.1332.001 15681797
-
(2004)
Ann N y Acad Sci
, vol.1035
, pp. 1-20
-
-
Turner, A.J.1
Fisk, L.2
Nalivaeva, N.N.3
-
16
-
-
27844497059
-
Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides
-
10.1074/jbc.M508246200. 16162502
-
Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. P Marambaud H Zhao P Davies, J Biol Chem 2005 280 37377 37382 10.1074/jbc.M508246200 16162502
-
(2005)
J Biol Chem
, vol.280
, pp. 37377-37382
-
-
Marambaud, P.1
Zhao, H.2
Davies, P.3
|